SlideShare a Scribd company logo
1 of 26
Learning Objectives
• Identify normal hemodynamics
• Identify common conditions via their hemodynamics
• Understand Right Ventricular hemodynamics.
• Pitfalls in measuring hemodynamics
• Post Transplant Care
• Common Acute findings
• Biopsy schedule
“The Golden Hour”
• Sir R Adams Cowley “Father of Trauma
Medicine” 1975
• “There is a golden hour between life and
death. If a patient is critically injured he
has less than 60 minutes to survive. He
may not die right then: it may be a few
days, weeks, a month or a year later –
but something has happened in its body
that is irreparable”
Thiele H et al. IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with
cardiogenic shock. N Engl J Med. 2012 Oct 4;367(14):1287-96.
IABP-SHOCK II Trial Investigators IABP for cardiogenic
shock
Complete Reversal of Hypoperfusion in
30min of IABP from the SHOCK Registry
Ramanathan K, et al. Rapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in
cardiogenic shock complicating an acute myocardial infarction. Am Heart J. 2011 Aug;162(2):268-75. doi: 10.1016/j.ahj.2011.04.025.
Pulmonary Artery Catheter Use and Mortality in the Cardiac
Intensive Care Unit
Kadosh B, Berg D, Bohula E, et al. Pulmonary Artery Catheter Use and Mortality in the Cardiac
Intensive Care Unit. J Am Coll Cardiol HF. 2023
Cardiovascular hemodynamics
• What we measure:
– Intracardiac pressures
– Oxygen Saturations
• What we calculate:
– Cardiac Output and Index
– Qp [pulmonary flow]
– Qs [systemic blood flow]
– PVR and TPG
– SVR
– Gradients across valves
Cardiovascular hemodynamics
• Fluid filled catheter which transmits pressure wave from the heart
• Pressure transducer which converts pressure to electrical impulse
• Amplifier converts small electrical impulse converted to a pressure wave
Right atrial pressure waveforms
Right Ventricle pressure waveforms
• Systolic pressure
• Diastolic pressure
• Right ventricular End Diastolic
Pressure
Formulas
• FICK CO = Oxygen Consumption / (Arterial Sat – Mixed Venous Sat)*1.36*10*Hgb
• CI = CO/BSA
• SVR = (MAP – CVP) /CO * 80
• PVR = (PCWP – PA mean) / CO *80
• CPO = (CO * MAP) / 451
Cardiac Power is the best predictor of mortality in cardiogenic shock
Rupert Fincke et al. JACC 2004;44:340-348
American College of Cardiology Foundation
Defintion of Pulmonary Hypertension
• 2018 World Symposium of Pulmonary Hypertension
– PH is currently defined by mPAP >20 mmHg.
– “Pre-capillary pulmonary hypertension” is considered, if mPAP is >20 mmHg, PAWP is ≤15 mmHg
and PVR is ≥3 WU.
– “Post-capillary pulmonary hypertension” is defined as mPAP >20 mmHg with PAWP >15 mmHg. In
the case of PVR <3 WU, we talk about “isolated post-capillary pulmonary hypertension”, while in
the case of PVR ≥3 WU the criteria for “combined pre- and post-capillary pulmonary hypertension”
are fulfilled.
– Exercise PH is currently not part of the haemodynamic definition of PH.
– The evidence for the beneficial effects of PAH therapies is exclusively based on therapeutic trials
with PAH patients (or non-operable chronic thromboembolic PH) with mPAP ≥25 mmHg.
Hemodynamic Definitions of Pulmonary Hypertension Based
on Right-Heart Catheterization
mPAP (mmHg) PCWP (mmHg) PVR (WU) Group
Precapillary
pulmonary
hypertension
mPAP ≥ 20 ≤15 ≥3 1, 3, 4, 5
Isolated postcapillary
pulmonary
hypertension
mPAP ≥ 20 >15 <3 2, 5
Combined pre- and
postcapillary
pulmonary
hypertension
mPAP ≥ 20 >15 ≥3 2, 5
Abnormal Hemodynamics
• 1. PCWP 12, PA 80/20/40, RV 78/5/8, RA 8, CO 4.5, CI 2.5
• 2. PCWP 25, PA 50/25/33, RV 50/10/23, RA 23, CO 4, CI 1.9
• 3. PCWP 20, PA 45/20/31, RV 46/2/5, RA 5, CO 5, CI 2.5
• 4. PCWP 12, PA 45/20/28, RV 45/10/22, RA 22, CO 3.6, CI 1.8
• 5. PCWP 35, PA 60/35/41, RV 58/5/10, RA 10, CO 3, CI 1.5
• 6. PCWP 14, PA 25/3/10, RV 42/2/5, RA 5, CO 5, CI 2.5
1. Group I Pulm HTN
2. Constriction
3. HFpEF
4. RV failure
5. LV failure
Pitfalls
• ZERO
• TD vs. FICK
• PA Cath position
• Air bubble and Catheter whip
• Deep inspirations/Respiration Variation for TD and pressure tracing
Source: Reynolds H, Hochman J; Circulation 2008;117(5):686-697
Right Ventricle
The Spectrum of Acute MCS Devices in 2017
Left Ventricle
Matching Patients and AMCS Pumps
The Tufts Cardiogenic Shock Algorithm
Kapur & Esposito. Curr Cardiol. 2016
Pulmonary Artery Pulsatility Index as a predictor of RV failure
after LVAD
J Card Fail. 2016 Feb;22(2):110-6. doi: 10.1016/j.cardfail.2015.10.019. Epub 2015 Nov 10.
Inference of the survival benefit of current destination therapy with current continuous-flow
left ventricular assist device (LVAD) compared with medical management from the REMATCH
trial.
Soon J. Park et al. Circ Heart Fail. 2012;5:241-248
Copyright © American Heart Association, Inc. All rights reserved.
Case
• CC: chest tightness
• 65 yr old man with PMhx of CAD with hx of PCI of LAD 2 yrs ago, HTN, DM, HLD,
obesity, OSA.
• BP 90/70 HR 120 RR 24 O2sat 90% on RA
• SOB, cool extremities, thready pulse
• EKG with anterior V1-V3 2mm Elevations
• Next step?
Case Cont
• Cath lab for emergent PCI
• Found to have occluded LAD
• BP 70/40 MAP 50, Confused, Lactate 5
• Next step?
• Inotropes, RHC, MCS, CABG?
Case Cont
Support then PCI,
coronary perfusion, end organ preservation
MCS? IABP, Impella, ECMO
Right heart cath hemodynamics2.pptx

More Related Content

Similar to Right heart cath hemodynamics2.pptx

Shunt quantification and reversibility
Shunt quantification and reversibilityShunt quantification and reversibility
Shunt quantification and reversibilityGOPAL GHOSH
 
Pulmonary artery hypertension
Pulmonary artery hypertensionPulmonary artery hypertension
Pulmonary artery hypertensionravitheja94
 
Can we be intensive and non-invasive? by Professor Michael Pinsky
Can we be intensive and non-invasive? by Professor Michael PinskyCan we be intensive and non-invasive? by Professor Michael Pinsky
Can we be intensive and non-invasive? by Professor Michael PinskyCICM 2019 Annual Scientific Meeting
 
2nd world congress on biomarker's and clinical research
2nd world congress on biomarker's and clinical research2nd world congress on biomarker's and clinical research
2nd world congress on biomarker's and clinical researchSULE AKIN
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertensionkirti jangra
 
Heart Disease & Chest Pain Treatment At NT Cardiovascular Center Georgia
Heart Disease & Chest Pain Treatment At NT Cardiovascular Center GeorgiaHeart Disease & Chest Pain Treatment At NT Cardiovascular Center Georgia
Heart Disease & Chest Pain Treatment At NT Cardiovascular Center Georgiamelvillejackson
 
PH in the Real World_Case Studies.pptx
PH in the Real World_Case Studies.pptxPH in the Real World_Case Studies.pptx
PH in the Real World_Case Studies.pptxDuke Heart
 
cardiac output measurment and monitoring ppt-1.pptx
cardiac output measurment and monitoring ppt-1.pptxcardiac output measurment and monitoring ppt-1.pptx
cardiac output measurment and monitoring ppt-1.pptxshekinah41
 
Pulmonary embolism in Emergency Department v2.0
Pulmonary embolism in Emergency Department v2.0Pulmonary embolism in Emergency Department v2.0
Pulmonary embolism in Emergency Department v2.0drbarai
 
management of pulmonary embolism in emergency department
management of pulmonary embolism in emergency departmentmanagement of pulmonary embolism in emergency department
management of pulmonary embolism in emergency departmentMustafaSafaa8
 
Microsoft Power Point Cardiovascular Disorders Ebi
Microsoft Power Point   Cardiovascular Disorders EbiMicrosoft Power Point   Cardiovascular Disorders Ebi
Microsoft Power Point Cardiovascular Disorders EbiNio Noveno
 

Similar to Right heart cath hemodynamics2.pptx (20)

Shunt quantification and reversibility
Shunt quantification and reversibilityShunt quantification and reversibility
Shunt quantification and reversibility
 
Dagm
DagmDagm
Dagm
 
Difficult Airway in Polytrauma.pptx
Difficult Airway in Polytrauma.pptxDifficult Airway in Polytrauma.pptx
Difficult Airway in Polytrauma.pptx
 
Pulmonary artery hypertension
Pulmonary artery hypertensionPulmonary artery hypertension
Pulmonary artery hypertension
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
Can we be intensive and non-invasive? by Professor Michael Pinsky
Can we be intensive and non-invasive? by Professor Michael PinskyCan we be intensive and non-invasive? by Professor Michael Pinsky
Can we be intensive and non-invasive? by Professor Michael Pinsky
 
2nd world congress on biomarker's and clinical research
2nd world congress on biomarker's and clinical research2nd world congress on biomarker's and clinical research
2nd world congress on biomarker's and clinical research
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertension
 
Pah seminar kirti
Pah seminar kirtiPah seminar kirti
Pah seminar kirti
 
Pulmonary Arterial Hypertension: The Other High Blood Pressure
Pulmonary Arterial Hypertension: The Other High Blood PressurePulmonary Arterial Hypertension: The Other High Blood Pressure
Pulmonary Arterial Hypertension: The Other High Blood Pressure
 
Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shock
 
PHT ECHO.pptx
PHT ECHO.pptxPHT ECHO.pptx
PHT ECHO.pptx
 
Shock
Shock Shock
Shock
 
Heart Disease & Chest Pain Treatment At NT Cardiovascular Center Georgia
Heart Disease & Chest Pain Treatment At NT Cardiovascular Center GeorgiaHeart Disease & Chest Pain Treatment At NT Cardiovascular Center Georgia
Heart Disease & Chest Pain Treatment At NT Cardiovascular Center Georgia
 
PH in the Real World_Case Studies.pptx
PH in the Real World_Case Studies.pptxPH in the Real World_Case Studies.pptx
PH in the Real World_Case Studies.pptx
 
cardiac output measurment and monitoring ppt-1.pptx
cardiac output measurment and monitoring ppt-1.pptxcardiac output measurment and monitoring ppt-1.pptx
cardiac output measurment and monitoring ppt-1.pptx
 
Pulmonary Arterial Hypertension Overview for Scleroderma Patients
Pulmonary Arterial Hypertension Overview for Scleroderma PatientsPulmonary Arterial Hypertension Overview for Scleroderma Patients
Pulmonary Arterial Hypertension Overview for Scleroderma Patients
 
Pulmonary embolism in Emergency Department v2.0
Pulmonary embolism in Emergency Department v2.0Pulmonary embolism in Emergency Department v2.0
Pulmonary embolism in Emergency Department v2.0
 
management of pulmonary embolism in emergency department
management of pulmonary embolism in emergency departmentmanagement of pulmonary embolism in emergency department
management of pulmonary embolism in emergency department
 
Microsoft Power Point Cardiovascular Disorders Ebi
Microsoft Power Point   Cardiovascular Disorders EbiMicrosoft Power Point   Cardiovascular Disorders Ebi
Microsoft Power Point Cardiovascular Disorders Ebi
 

Recently uploaded

High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7grandmotherprocess99
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUELMKARTHIKEMMANUEL
 
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door StepBangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Stepdarmandersingh4580
 
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptxGross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptxDr. Rabia Inam Gandapore
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 
Benefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdfBenefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdfLearnyoga
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024locantocallgirl01
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019Akash Agnihotri
 
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...JRRolfNeuqelet
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxMohammadAbuzar19
 
parliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdfparliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdfDr. Nasir Mustafa
 
Anti viral drug pharmacology classification
Anti viral drug pharmacology classificationAnti viral drug pharmacology classification
Anti viral drug pharmacology classificationNikitaPawar41153
 
The Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project
 
duus neurology.pdf anatomy. phisiology///
duus neurology.pdf anatomy. phisiology///duus neurology.pdf anatomy. phisiology///
duus neurology.pdf anatomy. phisiology///sofia95y
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?bkling
 
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptxCreeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptxYasser Alzainy
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsYash Garg
 
Sell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stockSell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stocktammysayles9
 

Recently uploaded (20)

High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door StepBangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
 
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptxGross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
 
Benefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdfBenefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdf
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
 
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptx
 
parliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdfparliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdf
 
Anti viral drug pharmacology classification
Anti viral drug pharmacology classificationAnti viral drug pharmacology classification
Anti viral drug pharmacology classification
 
The Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - Subconscious
 
duus neurology.pdf anatomy. phisiology///
duus neurology.pdf anatomy. phisiology///duus neurology.pdf anatomy. phisiology///
duus neurology.pdf anatomy. phisiology///
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?
 
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptxCreeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
 
Sell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stockSell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stock
 
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
 

Right heart cath hemodynamics2.pptx

  • 1. Learning Objectives • Identify normal hemodynamics • Identify common conditions via their hemodynamics • Understand Right Ventricular hemodynamics. • Pitfalls in measuring hemodynamics • Post Transplant Care • Common Acute findings • Biopsy schedule
  • 2. “The Golden Hour” • Sir R Adams Cowley “Father of Trauma Medicine” 1975 • “There is a golden hour between life and death. If a patient is critically injured he has less than 60 minutes to survive. He may not die right then: it may be a few days, weeks, a month or a year later – but something has happened in its body that is irreparable”
  • 3. Thiele H et al. IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012 Oct 4;367(14):1287-96. IABP-SHOCK II Trial Investigators IABP for cardiogenic shock
  • 4. Complete Reversal of Hypoperfusion in 30min of IABP from the SHOCK Registry Ramanathan K, et al. Rapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarction. Am Heart J. 2011 Aug;162(2):268-75. doi: 10.1016/j.ahj.2011.04.025.
  • 5. Pulmonary Artery Catheter Use and Mortality in the Cardiac Intensive Care Unit Kadosh B, Berg D, Bohula E, et al. Pulmonary Artery Catheter Use and Mortality in the Cardiac Intensive Care Unit. J Am Coll Cardiol HF. 2023
  • 6. Cardiovascular hemodynamics • What we measure: – Intracardiac pressures – Oxygen Saturations • What we calculate: – Cardiac Output and Index – Qp [pulmonary flow] – Qs [systemic blood flow] – PVR and TPG – SVR – Gradients across valves
  • 7. Cardiovascular hemodynamics • Fluid filled catheter which transmits pressure wave from the heart • Pressure transducer which converts pressure to electrical impulse • Amplifier converts small electrical impulse converted to a pressure wave
  • 9.
  • 10. Right Ventricle pressure waveforms • Systolic pressure • Diastolic pressure • Right ventricular End Diastolic Pressure
  • 11. Formulas • FICK CO = Oxygen Consumption / (Arterial Sat – Mixed Venous Sat)*1.36*10*Hgb • CI = CO/BSA • SVR = (MAP – CVP) /CO * 80 • PVR = (PCWP – PA mean) / CO *80 • CPO = (CO * MAP) / 451
  • 12. Cardiac Power is the best predictor of mortality in cardiogenic shock Rupert Fincke et al. JACC 2004;44:340-348 American College of Cardiology Foundation
  • 13.
  • 14. Defintion of Pulmonary Hypertension • 2018 World Symposium of Pulmonary Hypertension – PH is currently defined by mPAP >20 mmHg. – “Pre-capillary pulmonary hypertension” is considered, if mPAP is >20 mmHg, PAWP is ≤15 mmHg and PVR is ≥3 WU. – “Post-capillary pulmonary hypertension” is defined as mPAP >20 mmHg with PAWP >15 mmHg. In the case of PVR <3 WU, we talk about “isolated post-capillary pulmonary hypertension”, while in the case of PVR ≥3 WU the criteria for “combined pre- and post-capillary pulmonary hypertension” are fulfilled. – Exercise PH is currently not part of the haemodynamic definition of PH. – The evidence for the beneficial effects of PAH therapies is exclusively based on therapeutic trials with PAH patients (or non-operable chronic thromboembolic PH) with mPAP ≥25 mmHg.
  • 15. Hemodynamic Definitions of Pulmonary Hypertension Based on Right-Heart Catheterization mPAP (mmHg) PCWP (mmHg) PVR (WU) Group Precapillary pulmonary hypertension mPAP ≥ 20 ≤15 ≥3 1, 3, 4, 5 Isolated postcapillary pulmonary hypertension mPAP ≥ 20 >15 <3 2, 5 Combined pre- and postcapillary pulmonary hypertension mPAP ≥ 20 >15 ≥3 2, 5
  • 16. Abnormal Hemodynamics • 1. PCWP 12, PA 80/20/40, RV 78/5/8, RA 8, CO 4.5, CI 2.5 • 2. PCWP 25, PA 50/25/33, RV 50/10/23, RA 23, CO 4, CI 1.9 • 3. PCWP 20, PA 45/20/31, RV 46/2/5, RA 5, CO 5, CI 2.5 • 4. PCWP 12, PA 45/20/28, RV 45/10/22, RA 22, CO 3.6, CI 1.8 • 5. PCWP 35, PA 60/35/41, RV 58/5/10, RA 10, CO 3, CI 1.5 • 6. PCWP 14, PA 25/3/10, RV 42/2/5, RA 5, CO 5, CI 2.5 1. Group I Pulm HTN 2. Constriction 3. HFpEF 4. RV failure 5. LV failure
  • 17. Pitfalls • ZERO • TD vs. FICK • PA Cath position • Air bubble and Catheter whip • Deep inspirations/Respiration Variation for TD and pressure tracing Source: Reynolds H, Hochman J; Circulation 2008;117(5):686-697
  • 18. Right Ventricle The Spectrum of Acute MCS Devices in 2017 Left Ventricle
  • 19. Matching Patients and AMCS Pumps The Tufts Cardiogenic Shock Algorithm Kapur & Esposito. Curr Cardiol. 2016
  • 20. Pulmonary Artery Pulsatility Index as a predictor of RV failure after LVAD J Card Fail. 2016 Feb;22(2):110-6. doi: 10.1016/j.cardfail.2015.10.019. Epub 2015 Nov 10.
  • 21.
  • 22. Inference of the survival benefit of current destination therapy with current continuous-flow left ventricular assist device (LVAD) compared with medical management from the REMATCH trial. Soon J. Park et al. Circ Heart Fail. 2012;5:241-248 Copyright © American Heart Association, Inc. All rights reserved.
  • 23. Case • CC: chest tightness • 65 yr old man with PMhx of CAD with hx of PCI of LAD 2 yrs ago, HTN, DM, HLD, obesity, OSA. • BP 90/70 HR 120 RR 24 O2sat 90% on RA • SOB, cool extremities, thready pulse • EKG with anterior V1-V3 2mm Elevations • Next step?
  • 24. Case Cont • Cath lab for emergent PCI • Found to have occluded LAD • BP 70/40 MAP 50, Confused, Lactate 5 • Next step? • Inotropes, RHC, MCS, CABG?
  • 25. Case Cont Support then PCI, coronary perfusion, end organ preservation MCS? IABP, Impella, ECMO

Editor's Notes

  1. Unadjusted estimated in-hospital mortality by cardiac power output (n = 189) with pointwise 95% confidence bands.
  2. Inference of the survival benefit of current destination therapy with current continuous-flow left ventricular assist device (LVAD) compared with medical management from the REMATCH trial. HMII indicates HeartMate II.